Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
מצבים רפואיים
Hepatocellular Carcinoma · Biliary Tract Cancer
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Beverly Hills Cancer Center, Beverly Hills, California, United States
Contact: Study coordinator (Afshin Eli Gabayan, MD)UC San Diego Moores Cancer Center, La Jolla, California, United States
Contact: Study coordinator (Adam Burgoyne, MD)Sylvester Comprehensive Cancer Center (University of Miami Hospital and Clinics), Miami, Florida, United States
Contact: Study coordinator (Lynn Goy Feun, MD)Moffitt Cancer Center, Tampa, Florida, United States
Contact: Study coordinator (Richard Kim, MD)University of Maryland Medical Center, Baltimore, Maryland, United States
Contact: Study coordinator (Kevin"Hyun" Kim, MD)Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States
Contact: Study coordinator (Renuka Iyer, MD)Montefiore Medical CenterMontefiore Medical Park, The Bronx, New York, United States
Contact: Study coordinator (Yvonne Saenger,, MD)University of Pennsylvania, Abramson Cancer Center, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (William Chapin, MD)UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
Contact: Study coordinator (Anwaar Saeed, MD.)The West Clinic, Germantown, Tennessee, United States
Contact: Study coordinator (Axel Grothey, MD)University of Tennessee Medical Center, Knoxville, Tennessee, United States
Contact: Study coordinator (Saikrishna Gadde, MD)Houston Methodist Hospital Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Maen Abdelrahim, MD)
מובילי המחקר
Gary Vanasse, MD
Study Director
Replimune, Inc.